Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
CRISPR Therapeutics AG
Swot
CRISPR Therapeutics AG SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
CRISPR Therapeutics AG has 8 Strengths, 14 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(14)
Opportunity
(1)
Threats
(2)
Others
(0)
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Top Losers
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
